TipRanks
Go Ultimate55% OFF

Genprex (GNPX) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Atezolizumab, Quaratusugene OzeplasmidSmall Cell Lung Cancer Extensive Stagephase1AndPhase2RecruitingQuaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC PatientsJan 19, 2023―
Pembrolizumab, Docetaxel, Ramucirumab, Quaratusugene Ozeplasmid, Investigator's Treatment Of ChoiceNon Small Cell Lung Cancerphase1AndPhase2TerminatedQuaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung CancerSep 20, 2021―
Osimertinib, Platinum-Based Chemotherapy, Quaratusugene OzeplasmidCarcinoma, Non-Small Cell Lungphase1AndPhase2RecruitingQuaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibJul 22, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Genprex (GNPX) have in its pipeline
Genprex GNPX is currently developing the following drugs: Atezolizumab, Quaratusugene Ozeplasmid, Pembrolizumab, Docetaxel, Ramucirumab, Quaratusugene Ozeplasmid, Investigator's Treatment Of Choice, Osimertinib, Platinum-Based Chemotherapy, Quaratusugene Ozeplasmid. These drug candidates are in various stages of clinical development as the company works toward FDA approval.